TUCSON, Ariz., Dec. 20, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM), a provider of instruments, reagents and services
for molecular profiling applications, today announced that its senior management team will host institutional investor and
partnering meetings at the LifeSci Advisors Corporate Access Event taking place in San Francisco, January 8-10, 2018.
To schedule a meeting with HTG Molecular, investors can register on the online system managed by the Company’s US investor relations firm, LifeSci Advisors, LLC, or make a request via e-mail at Access@LifeSciAdvisors.com.
About HTG:
Headquartered in Tucson, Arizona, the mission of HTG is to empower precision medicine at the local level. The company’s
HTG EdgeSeq technology, which automates highly multiplexed molecular profiling of small samples for next-generation
sequencing, received its first US patent in 2014. Continuous improvements led to the 2017 launch of HTG’s new direct-target
sequencing chemistry for DNA analysis offered in the company’s VERI/O services laboratory. Additional information is available at
www.htgmolecular.com.
Contact:
LifeSci Advisors, LLC
Ashley Robinson
Phone: (617) 775-5956
Email: arr@lifesciadvisors.com
TJ Johnson
President / CEO
HTG Molecular Diagnostics
Phone: (520) 547-2827 x130
Email: tjjohnson@htgmolecular.com
